bioRxivBiochemistryPreprint
Discovery of Chirally-dependent Protein O-2-Hydroxyglutarylation by D2HG and L2HG
Zheng ZhangiD, Yi‐Kai LiuiD, Zhuojun LuoiD, Meng‐Ju WuiD, Claudia N. EvansiD, Zihan QuiD, Fanglei XueiD, Zhong‐Yin ZhangiD, Elizabeth I. ParkinsoniD, Nabeel M. BardeesyiD, W. Andy TaoiD
Abstract
Mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 are common in multiple types of human cancer, leading to the accumulation of D-2-hydroxyglutarate (D2HG) and the promotion of tumorigenesis1. Here we discovered a novel O-2- hydroxyglutarylation by D2HG using chemical proteomics and further revealed distinct chiral preferences for D/L2HG modifications. Notably, we identified two kinases, MRCKA and SLK, modified by D2HG and L2HG respectively, and detected reduced phosphorylation of their substrates, suggesting an inhibitory effect of D/L 2HG modifications on the kinases activity.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- New alleles of D-2-hydroxyglutarate dehydrogenase enable studies of oncometabolite function in Drosophila melanogaster
Madhulika Rai, Prince Okah, … Jason M. Tennessen·G3 Genes Genomes GeneticsPeer-reviewed·Jun 9, 2025
- Lysine-R2HGylation identified as a post-translational modification in R2HG-elevated cancers
Qian Zhao, Peiwu Huang, … Dan Yang·bioRxiv·Oct 3, 2025
- Assessing Inhibitors Of Mutant Isocitrate Dehydrogenase Using A Suite Of Pre-Clinical Discovery Assays
D. J. Urban, N. J. Martinez, … M. D. Hall·bioRxiv·Apr 7, 2017
- Resolving Challenges in Detection and Quantification of D-2-hydroxyglutarate and L-2-hydroxyglutarate via LC/MS
Tyrone Dowdy, Mioara Larion·MethodsPeer-reviewed·Aug 22, 2026
- A genetically encoded fluorescent sensor enables sensitive and specific detection of IDH mutant associated oncometabolite D-2-hydroxyglutarate
Kristian A. Choate, W. W. L. Konickson, … Evan P.S. Pratt·BMC CancerPeer-reviewed·Mar 14, 2025
- Isoform switching as a mechanism of acquired resistance to isocitrate dehydrogenase inhibition
J. J. Harding, M. A. Lowery, … A. M. Intlekofer·bioRxiv·Aug 1, 2018